Related Experiment Video
Updated: Jan 9, 2026

The In ovo CAM-assay as a Xenograft Model for Sarcoma
Published on: July 17, 2013
Cardiac Angiosarcoma
Chu Chen1,2,3, Songlin Zhang4, Jian Yang2,3,5
1Central Laboratory, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital.
Insights
Primary cardiac angiosarcoma, an aggressive cancer, presents unique challenges. This case highlights a patient with right atrial angiosarcoma, treated with multimodal therapy, surviving 11 months.
Area of Science:
- Cardiovascular Pathology
- Cardiac Oncology
- Medical Oncology
Background:
- Angiosarcoma is the most aggressive primary malignant cardiac tumor.
- It typically involves the right atrium and presents with nonspecific symptoms.
- High invasiveness and rapid progression characterize this rare malignancy.
Purpose of the Study:
- To report a case of primary cardiac angiosarcoma.
- To discuss the diagnostic and therapeutic challenges.
- To emphasize the need for evidence-based treatment guidelines.
Main Methods:
- Case presentation of a patient with recurrent hemorrhagic pericardial effusion and cardiac tamponade.
- Diagnostic imaging revealed a right atrial mass.
- Surgical resection followed by histopathological confirmation of angiosarcoma.
Main Results:
- Intraoperative findings confirmed extensive invasion into the pericardium and adjacent structures.
- The patient underwent partial palliative resection.
- Post-operative treatment included chemotherapy, immunotherapy, and targeted therapy, achieving 11 months of overall survival.
Conclusions:
- Primary cardiac angiosarcoma requires a multidisciplinary approach.
- Current therapeutic strategies present significant challenges.
- Further research is needed to develop effective treatment guidelines for improved patient outcomes.
Abstract:
Angiosarcoma is the most aggressive primary malignant cardiac tumor, typically involving the right atrium and characterized by its high invasiveness, rapid progression, and nonspecific clinical manifestations. The patient presented with recurrent hemorrhagic pericardial effusion and cardiac tamponade. Imaging revealed a right atrial mass, and intraoperative findings confirmed extensive invasion into the pericardium and adjacent structures, necessitating a partial palliative resection. Histopathological examination confirmed the diagnosis of angiosarcoma. After surgery, the patient received a combination regimen of chemotherapy, immunotherapy, and targeted therapy, with an overall survival of 11 months. A deeper understanding of this disease, clarification of the therapeutic challenges, and the development of evidence-based treatment guidelines are needed to provide more reliable and potentially life-saving strategies for patients with this disease.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Angina I: Introduction
Angina III: Clinical Manifestations and Assessment
Acute Coronary Syndrome I: Introduction

